Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous entry v3.6.6 was removed. This updates the page’s revision history to reflect the latest version of the record.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history now lists a new latest revision: v3.6.6, replacing v3.6.5. This indicates a minor update to the study record history.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This reflects a maintenance update to the record history rather than changes to the study data.SummaryDifference0.1%

- Check76 days agoChange Detected- The history now includes a new page revision entry for v3.6.4, replacing v3.6.3. This indicates an update to the page's record.SummaryDifference0.1%

- Check97 days agoChange DetectedNew revision number v3.6.3 is now shown, replacing the previous v3.6.2. This indicates the study record has been updated to a newer version, reflecting changes since the prior revision.SummaryDifference0.1%

- Check105 days agoChange DetectedThe revision history now shows a new revision entry (v3.6.2). This update reflects an update to the page's versioning record rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.